Related Experiment Videos
Polymyositis associated with asymptomatic primary biliary cirrhosis
J Bondeson1, B Veress, Y Lindroth
1Department of Rheumatology, Malmö University Hospital, Sweden.
Clinical and Experimental Rheumatology
|April 16, 1998
Summary
This case study highlights polymyositis linked to primary biliary cirrhosis and antimitochondrial antibodies. Treatment with immunosuppressants led to a positive outcome in this patient with multiorgan involvement.
Area of Science:
- Rheumatology
- Immunology
- Hepatology
Background:
- Polymyositis is an idiopathic inflammatory myopathy characterized by symmetrical muscle weakness.
- Primary biliary cirrhosis (PBC) is a chronic liver disease associated with autoimmune phenomena.
- Antimitochondrial antibodies (AMAs) are serological markers often found in PBC.
Observation:
- A patient presented with polymyositis and concurrent asymptomatic primary biliary cirrhosis.
- High titers of antimitochondrial antibodies were detected.
- The patient exhibited significant multiorgan involvement, including polyarthritis, pericarditis, pleuritis, and tachyarrhythmia.
Findings:
- Muscle biopsy revealed atypical changes suggestive of mitochondrial damage.
- The observed symptoms indicated a complex interplay between autoimmune conditions.
- The patient's condition demonstrated a rare association between polymyositis and primary biliary cirrhosis.
Implications:
- This case underscores the importance of considering systemic autoimmune diseases in polymyositis patients.
- It highlights the potential for multiorgan manifestations in patients with primary biliary cirrhosis and high AMA titers.
- Effective management with immunosuppressive therapy (azathioprine and steroids) can lead to favorable outcomes in such complex cases.